Agenus Inc

NASDAQ:AGEN  
4.48
-0.26 (-5.48%)
6:09:32 PM EDT: $4.57 +0.09 (+2.01%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)134.93M
Current PEN/A
Forward PE 5.6
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$80.39 Million
Adjusted EPS$2.20
See more estimates
10-Day MA$4.56
50-Day MA$5.17
200-Day MA$3.69
See more pivots

Agenus Inc Stock, NASDAQ:AGEN

3 Forbes Road, Lexington, Massachusetts 02421-7305
United States of America
Phone: +1.781.674.4400
Number of Employees: 316

Description

Agenus, Inc. is a clinical-stage company, which engages in the development and commercialization of technologies to treat cancers and infectious diseases. Its product pipeline includes Balstilimab, Zalifrelimab, AGEN1181, AGEN1327, AGEN2373, AGENt-797 and AGEN1777. The company was founded by Garo H. Armen and Pramod K. Srivastava on March 31, 1994 and is headquartered in Lexington, MA.